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1. Introduction 
The biosynthesis of rRNA in animal cells appears 
to be more sensitive to a variety of inhibitors as com- 
pared to non-ribosomal RNA species (see [l] ). Perry 
et al. [2] proposed that the higher sensitivity of 
rRNA synthesis to actinomycin D may be due to the 
sequential transcription of clustered rRNA genes. The 
model would explain the preferential inhibition of 
rRNA synthesis by inhibitors acting on the DNA 
template. However, a preferential inhibition of rR_NA 
synthesis was observed also with cordycepin [3] , 
causing the termination of growing RNA chains, and 
even with the non-specific inhibitor, 2,4-dinitrophe- 
no1 [4] . Therefore, factors besides the structure of 
rRNA genes may be also important in conferring a 
higher sensitivity to rRNA synthesis. 
The exotoxin of Bat. fhiiringiensis has been iso- 
lated and characterized chemically by Sebesta et al. 
[5, 61 as a structural analogue of ATP. In the present 
work it is shown that in vivo administration of low 
doses of Bat. thiiringiensis exotoxin inhibits more 
strongly the synthesis of liver rRNA, while the syn- 
thesis of nuclear “DNA-like” RNA is less affected. 
Part of these results has been reported previously [7]. 
2. Methods 
2.1. Conditions of in vivo labelling 
Experiments were carried out with albino mice of 
20-25 g body weight. The highly purified exotoxin 
North-Holland Atblishing Company - Amsterdam 
was dissolved in saline and injected i.p. simultane- 
ously with 200 /Xi of carrier-free 32P-phosphate or 
15 /Xi of 6-14C-orotic acid (specific activity 15 .I 
mCi per mmole). In another set of experiments the 
exotoxin was given 30 mm before the administration 
of 6-i4C-erotic acid. 
2.2. Isolation and fractionation of nuclear RNAs 
A 10% liver homogenate in 0.14 M NaCl was 
mixed immediately with an equal volume of cold 
phenol saturated with 0.14 M NaCl pH 6.0 containing 
0.1% &hydroxyquinoline. The mixture was shaken 
for 15 min at 4” and centrifuged at 5000 rpm in the 
cold. The water layer, containing the “cytoplasmic 
RNA” fraction was aspirated and discarded. The 
nuclear RNAs, entrapped in the interphase layer, 
were extracted by hot phenol treatment at different 
temperatures according to Georgiev [8] . The fraction 
of nuclear “rRNA” was extracted at 45”, while the 
fraction of nuclear “DNA-like RNA” was extracted 
from the residual interphase layer at 85”. 
2.3. firiji2ation ofRNA preparations 
The nuclear RNA fractions were deproteinized 
3-5 times with cold phenol and freed from 32P-phos- 
phate and other contaminants by passage through a 
column of Dowex-1, formate form. The nuclear 
“DNA-like RNA” was freed from DNA by treatment 
with deoxyribonuclease I (Worthington) at a concen- 
tration of 10 pg per ml for 30 min at 25”. After hy- 
drolysis the mixture was deproteimzed 3 times with 
cold phenol and RNA precipitated with 3 vol of 96% 
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Fig. 1. Inhibition of the in vivo nP-phosphate incorporation 
into total high molecular weight RNA of mouse liver by the 
Bat. thiiringiensis exotoxin. The animals were injected i. p. 
simultaneously with 200 &i per mouse of carrier-free =P- 
phosphate and varying amounts of Bat. thiiringiensis exotoxin 
for 90 min. 
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2.5. Nucleotide composition of RNA 
The nucleotide composition of total and 32P-la- 
belled RNA was determined by Katz and Comb [lo] 
as specified previously [4] . 
ethanol containing 1% potassium acetate. 
2.4. Agar gel electrophoresis of RNA 
3.2. Inhibition of nuclear “ribosomal” and “DNA-like” 
RNA synthesis 
This was carried out according to the technique The rate of labelling of nuclear “DNA-like” RNA 
of Tsanev and Staynov [9] under conditions specified in control mice is 5-IO-fold higher than that of 
in a previous paper [4]. In some experiments the nuclear rRNA. Following exotoxin treatment the 
dried agar gel film was sectioned at 2 mm and each labelling of nuclear rRNA is inhibited by 90-95%. 
section counted in a Packard “TriGarb” scintillation On the other hand, with the same doses of exotoxin, 
spectrometer with a toluene-PPO-POPOP phosphor. a rather high labelling of nuclear “DNA-like” RNA is 
3. Results 
3 .l . Inhibition of in vivo nuclear RNA synthesis 
In a first series of experiments the effect of in- 
creasing doses of exotoxin on the labelling of total 
mouse liver RNA was followed. The results (fig. 1) 
show, in agreement with previous studies [ 111 that 
the exotoxin of Bat. thiiringiensis inhibits the in 
vivo synthesis of liver RNA. The inhibitory effect is 
dose dependent. About 70% inhibition of 32P-phos- 
phate incorporation is attained by 0.5 mg exotoxin 
per mouse. However, the inhibition reaches a satura- 
tion level at doses of about 1 mg per mouse, thus in- 
dicating the existence in nuclei of some exotoxin re- 
sistant RNA synthesis. 
Table 1 
Inhibition of the incorporation of 6-“C-erotic acid into nuclear 
“ribosomal” and “DNA-like” RNA fractions of mouse liver by the exotoxin 
of Bat. thiiringiensis. 
RNA 
fraction 
Labelling 
time (mm) 
Exotoxin* 
(mg/mouse) 
Specific activity of 
RNA (counts/mm per 
Aam unit of RNA) 
Residual 
incorporation 
(%) 
Control Exotoxin 
treated 
“Ribosomal” 60 0.5 1,490 110 1.4 
120 0.15 4,753 578 12.0 
“DNA-like” 60 0.5 17,592 4,354 24.8 
120 0.15 25,427 13,376 52.6 
* The exotoxin was given intraperitoneally 30 min before the labelled precursor. 
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F$2. Agar gel electrophoresis of nuclear “ribosomal” (A, B, C and D) and ‘*DNA-like” (E and F) RNA of mouse liver after 
6- C-erotic acid labelling in viva for 20 min (A), 60 min (B) and 120 min (C, D, E and F). The agar gel electrophoresis profiles 
of RNAs from control (A, B, C and E) and pretreated for 30 mm with the Bat. thuringiensis exotoxin (D and F) mice are pre- 
sented. ( -_): Absorbancy recorded at 260 nm. (--------): Radioactivity recorded at 550 nm. 
found, which amounts to about 2550% of the la- 
belling in control mice (table 1). 
3.3. Nucleotide composition of nuclear RNA fractions 
The CC/AU ratio of 1.60 obtained for the nuclear 
“rRNA” fraction is identical to that of cytoplasmic 
rRNA [l] . On the other hand, the GC/AU ratio of 
0.88 recorded for the nuclear “DNA-like” RNA frac- 
tion reveals that when extracted under strictly speci- 
fied conditions this fraction is clearly non-ribosomal 
by nucleotide composition. The composition of both 
labelled nuclear RNA fractions was identical to that 
of the total RNA in each fraction. Inhibition of RNA 
synthesis by the Bat. thiiringiensis exotoxin does not 
cause any significant change in the nucleotide compo- 
sition of either the total or the rapidly labelled com- 
ponents of the 2 nuclear RNA fractions studied. 
3.4. Agar gel electrophoresis of nuclear RNA fractions 
Information on the distribution of the label among 
different RNA species in the 2 nuclear fractions stud- 
ied was obtained by agar gel electrophoresis (fig. 2). 
The nuclear “rRNA” fraction yields an electropho- 
retie profile with clearly delineated 28 S and 18 S 
RNA peaks [ 121 . The radioactivity profile of nuclear 
“rRNA” from control mice shows that the label is 
located mainly in fractions moving more slowly than 
28 S RNA. At 20 min labelling, the radioactivity is 
mainly in the 45 S rRNA precursor. At longer times 
of labelling it is shifted to the 32 S and 18 S rRNA 
fractions, as well as to some minor fractions in the 
region between 28 S and 18 S RNA. Exotoxin pre- 
treatment of mice abolished almost completely the 
labelling of the rRNA precursors, as well as the RNA 
fractions in the zone of the 2 rRNA peaks. 
The UV-profile of the nuclear “DNA-like” RNA 
fraction shows a heterogeneous distribution with a 
clearly delimited peak in the zone of 18 S RNA [ 121. 
Exotoxin administration does not change the recorded 
W-profile. The distribution of the rapidly labelled 
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components is heterogeneous, the labelled species 
moving more slowly than the bulk of the UV-absorb- 
ing material. The labelled RNA species in exotoxin 
treated mice show an identical distribution, which 
indicates that the exotoxin does not inhibit any par- 
ticular species of nuclear “DNA-like” RNA. Similar 
results were obtained in experiments where the exo- 
toxin was administered simultaneously with the la- 
belled precursor, 6-14C-orotate or 32P-phosphate. 
The presented results clearly show that in vivo the 
exotoxin of Bat. thiiringiensis inhibits preferentially 
the synthesis of rRNA. On the other hand, in vitro 
experiments revealed that low doses of exotoxin in- 
hibit much more strongly liver nucleoplasmic RNA 
polymerase and that it affects the enzyme molecule 
rather than the DNA template [13] . In this respect 
the exotoxin resembles a-amanitin, a highly selective 
inhibitor of liver nucleoplasmic RNA polymerase 
(see [ 141). Yet, when given in vivo both cr-amanitin 
[ 14,151 and the Bat. thiiringiensis exotoxin inhibit 
preferentially the synthesis of ribosomal RNA. The 
reason for the observed differences in the in vivo and 
in vitro action of these RNA polymerase inhibitors is 
not clear, but it is likely that both compounds might 
be useful in elucidating the higher sensitivity of rRNA 
synthesis in animal cells. 
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